ABCL
AbCellera Biologics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ABCL fundamentals
AbCellera Biologics (ABCL) released its earnings on Nov 6, 2025: revenue was 8.96M (YoY +37.62%), beat estimates; EPS was -0.19 (YoY -11.76%), missed estimates.
Revenue / YoY
8.96M
+37.62%
EPS / YoY
-0.19
-11.76%
Report date
Nov 6, 2025
ABCL Earnings Call Summary for Q3,2025
- Clinical Momentum: Phase I trials for ABCL635 and ABCL575 on track for 2026 readouts; $680M liquidity supports pipeline expansion.
- Leadership Shift: Dr. Sarah Noonberg appointed CMO to accelerate clinical development; Geoff Nichol departs after platform transition.
- Revenue Transition: Q3 revenue $9M (up 29% YoY), but R&D expenses rise to $55M as internal programs dominate focus.
- Strategic Focus: 103 partner programs in pipeline, with long-term value from downstream milestones; 4th internal candidate expected by year-end.
- Competitive Position: ABCL635 targets underserved VMS population; ABCL575 aims for 6-month dosing vs. 1-month competitors.
EPS
Revenue
Revenue & Expenses
ABCL has released its 2025 Q3 earnings report, with revenue of 8.96M, reflecting a YoY change of 37.62%, and net profit of -57.12M, showing a YoY change of -11.76%. The Sankey diagram below clearly presents ABCL's revenue sources and cost distribution.
Key Indicators
AbCellera Biologics (ABCL) key financial stats and ratios, covering profitability, financial health, and leverage.
AbCellera Biologics (ABCL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
AbCellera Biologics (ABCL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
AbCellera Biologics (ABCL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does AbCellera Biologics (ABCL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track AbCellera Biologics (ABCL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for AbCellera Biologics year over year?What were the key takeaways from AbCellera Biologics’s earnings call?What is AbCellera Biologics's latest dividend and current dividend yield?What is the market's earnings forecast for AbCellera Biologics next quarter?What guidance did AbCellera Biologics's management provide for the next earnings period?What factors drove the changes in AbCellera Biologics's revenue and profit?What is AbCellera Biologics's gross profit margin?What does AbCellera Biologics do and what are its main business segments?
